Incannex Healthcare (NASDAQ:IXHL) Releases Quarterly Earnings Results

Incannex Healthcare (NASDAQ:IXHL) announced its quarterly earnings data on Friday. The company reported ($0.33) EPS for the quarter, Zacks reports.

Incannex Healthcare Price Performance

NASDAQ IXHL traded down $0.02 on Friday, hitting $1.78. 37,933 shares of the company were exchanged, compared to its average volume of 86,802. Incannex Healthcare has a twelve month low of $1.50 and a twelve month high of $8.47. The firm has a market capitalization of $31.40 million, a P/E ratio of -1.28 and a beta of 7.44. The company’s 50 day moving average price is $1.85 and its 200-day moving average price is $1.92.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.